Zobrazeno 1 - 10
of 11
pro vyhledávání: '"J J Breeksema"'
Autor:
Wim van den Brink, Robert A. Schoevers, Jolien K E Veraart, Sanne Y Smith-Apeldoorn, J J Breeksema, Nina Schimmel
Publikováno v:
Psychopharmacology. 239:15-33
Background: Terminally ill patients may experience existential distress, depression, or anxiety, limiting quality of life in the final stage. Existing psychotherapeutic or pharmacological interventions have (time) limited efficacy. Psychedelic treatm
Autor:
Tijmen Bostoen, Erwin Krediet, Torsten Passie, Eric Vermetten, J J Breeksema, Annette van Schagen
Publikováno v:
International Journal of Neuropsychopharmacology
International Journal of Neuropsychopharmacology, 23(6), 385-400. OXFORD UNIV PRESS
International Journal of Neuropsychopharmacology, 23(6), 385-400. OXFORD UNIV PRESS
There are few medications with demonstrated efficacy for the treatment of posttraumatic stress disorder (PTSD). Treatment guidelines have unequivocally designated psychotherapy as a first line treatment for PTSD. Yet, even after psychotherapy, PTSD o
Autor:
Michiel van Elk, J J Breeksema
Publikováno v:
ACS Pharmacology & Translational Science, 4(4), 1471-1474
ACS Pharmacology & Translational Science, 4(4), 1471-1474. AMER CHEMICAL SOC INC
ACS Pharmacology & Translational Science, 4(4), 1471-1474. AMER CHEMICAL SOC INC
In response to a recent call to rid psychedelic science of the concept of mystical experience, we argue that acknowledging the varieties and weirdness of psychedelic experiences should be at the heart of any research program on this topic. We highlig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44909f7cf03c8eec3bb458379abe0cb1
https://doi.org/10.1021/acsptsci.1c00149
https://doi.org/10.1021/acsptsci.1c00149
Autor:
Jan van Amsterdam, Cees Maris, Raoul Pieter Joost Koning, Johannes G. Ramaekers, Gjalt-Jorn Peters, Ton Nabben, E.J.M. Pennings, Kaj Hollemans, Wim van den Brink, Floor van Bakkum, J J Breeksema, Tjibbe Reitsma, Tom Blickman, Willem Scholten, Judith Noijen
Publikováno v:
Amsterdam, J V, Peters, G-J Y, Pennings, E, Blickman, T, Hollemans, K, Breeksema, J J J, Ramaekers, J G, Maris, C, Bakkum, F V, Nabben, T, Scholten, W, Reitsma, T, Noijen, J, Koning, R & Brink, W V D 2021, ' Developing a new national MDMA policy : Results of a multi-decision multi-criterion decision analysis ', Journal of Psychopharmacology, vol. 35, no. 5, 0269881120981380, pp. 537-546 . https://doi.org/10.1177/0269881120981380
Journal of Psychopharmacology, 35(5):0269881120981380, 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Inc.
Journal of psychopharmacology (Oxford, England), 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5):0269881120981380, 537-546. SAGE Publications Ltd
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Inc.
Journal of psychopharmacology (Oxford, England), 35(5), 537-546. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology, 35(5), 537-546. SAGE Publications Ltd
Background: Ecstasy (3,4-methylenedioxymethamphetamine (MDMA)) has a relatively low harm and low dependence liability but is scheduled on List I of the Dutch Opium Act (‘hard drugs’). Concerns surrounding increasing MDMA-related criminality coupl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cf60f794eb5e34ad60b2743bb588d9
https://research.ou.nl/en/publications/5f18fe67-c218-4525-91f0-ee464bc8c268
https://research.ou.nl/en/publications/5f18fe67-c218-4525-91f0-ee464bc8c268
Autor:
J J, Breeksema, R A, Schoevers, E, Vermetten, R, Van, M, Destoop, T, Birkenhäger, W, van den Brink
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
After psychedelics were banned in 1968, the flourishing research on the use of psychedelics in patients with a mental disorder stopped abruptly. Recently, we see a renaissance of this research.br/AIM: To present an overview of what is known about the
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
Autor:
J J, Breeksema, W, van den Brink, J K E, Veraart, S Y, Smith-Apeldoorn, E, Vermetten, R A, Schoevers
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
There is a need for new, effective treatments for patients with (treatment-resistant) depressive disorders, anxiety disorders and obsessive-compulsive disorder (ocd). At the same time, there is renewed interest in psychedelics for the treatment of ps
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
Posttraumatic stress disorder (PTSD) is often a chronic condition, despite the availability of various evidence-based treatment options. Psychedelics offer new treatment opportunities.br/AIM: An overview of the current evidence, therapeutic context,
Autor:
S Y, Smith-Apeldoorn, J K E, Veraart, J, Kamphuis, J J, Breeksema, W, van den Brink, M, Aan Het Rot, R A, Schoevers
Publikováno v:
Tijdschrift voor psychiatrie. 62(8)
Treatment-resistance occurs in about 30% of patients with depression. Therefore, there is an urgent need to identify new treatment strategies. Ketamine, originally developed as an anesthetic, is studied and applied as treatment for patients with trea